MoneyWorks4Me

Clarification sought from Cipla

23 Mar 2017 Evaluate

The Exchange has sought clarification from Cipla with respect to news article appearing on ET NOW on March 23, 2017 titled ‘USFDA issued import alert on Ciplas Tadalafil drug made at Bhagwanpur unit.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..